Clozapine Drug-Drug Interactions and Individualized Dosing in Bipolar Disorder: A Model-Informed Precision Dosing...

Area of Science:

• Pharmacology
• Psychiatry
• Precision Medicine

Background:

• Clozapine is a vital treatment for bipolar disorder (BD).
• Drug-drug interactions (DDIs) with clozapine can compromise treatment efficacy and increase toxicity.
• Individualized dosing is crucial for optimizing clozapine therapy in BD patients.

Purpose of the Study:

• To investigate clozapine DDIs in BD patients using model-informed precision dosing (MIPD).
• To establish individualized clozapine administration regimens based on concomitant medications.
• To achieve precision medication for clozapine treatment in BD.

Main Methods:

• Collected data from 51 BD patients treated with clozapine and their concomitant medications.
• Applied MIPD techniques to identify potential DDIs.
• Utilized Monte Carlo simulations to determine optimal dosing regimens.

Main Results:

• Identified significant DDIs between clozapine and zopiclone or zolpidem tartrate.
• Established specific clozapine dosage recommendations based on patient weight and the presence of zopiclone or zolpidem tartrate.
• Provided weight-based clozapine dosing adjustments for patients with and without these interacting medications.

Conclusions:

• MIPD successfully identified clozapine DDIs in BD patients.
• The study offers weight- and drug-specific clozapine dosing guidelines.
• These recommendations aim to improve the safety and effectiveness of clozapine therapy for BD.